Zifcasiran
Zifcasiran (ADS-007; ARO HIF2) is an siRNA synthetic double-stranded RNAi trigger. Zifcasiran sodium selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). Zifcasiran sodium engages the cell's RNAi machinery to target HIF2α (EPAS1) mRNA for degradation, thereby reducing the amount of free HIF2α mRNA available for translation.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2437257-11-7
- Formel: C737H972F20N211O349P43S8
- Molecular Weight:20339.13
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 2437257-11-7
-
Molecular Weight 20339.13
-
Formel C737H972F20N211O349P43S8
-
SMILES
[Zifcasiran]
-
Synonyms
ADS-007; ARO HIF2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
- Zifcasiran
- 2437257-11-7
- ADS-007
- ARO HIF2
- ADS007
- ADS 007
- ARO HIF2
- ARO HIF 2
- ARO HIF-2
- Small Interfering RNA (siRNA)
- HIF/HIF Prolyl-Hydroxylase
- RNAi machinery
- HIF2α
- ccRCC tumorgrafts
- clear cell renal cell carcinoma
- HIF2α mRNA
- αvβ3 integrin ligand
- erythropoietin
- HIF1α mRNA
- nude mice
- HIF2α protein
- Inhibitor
- inhibitor
- inhibit